XML 54 R40.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 06, 2020
Jan. 03, 2020
Aug. 28, 2019
Apr. 29, 2019
Sep. 26, 2020
Sep. 28, 2019
Sep. 26, 2020
Sep. 28, 2019
Dec. 28, 2019
Cellero, LLC                  
Business Acquisition [Line Items]                  
Proposed purchase price $ 37,500                
Purchase price allocation 36,950                
Cash acquired 500                
Integration related costs and transaction costs         $ 2,000   $ 2,000    
Goodwill, amount expected to be deductible for tax purposes $ 10,800                
HemaCare Corporation                  
Business Acquisition [Line Items]                  
Proposed purchase price   $ 379,800              
Purchase price allocation   376,721              
Cash acquired   $ 3,100              
Integration related costs and transaction costs         100   5,900    
Actual revenue from acquiree         12,800   31,500    
Operating income (loss) from acquiree         400   (7,700)    
Citoxlab                  
Business Acquisition [Line Items]                  
Proposed purchase price       $ 527,100          
Purchase price allocation       490,357          
Cash acquired       36,700          
Integration related costs and transaction costs         600 $ 1,900 3,100 $ 19,100  
Goodwill, amount expected to be deductible for tax purposes       $ 7,200          
Other Acquisitions                  
Business Acquisition [Line Items]                  
Proposed purchase price     $ 23,400            
Purchase price allocation     23,063            
Cash acquired     300            
Integration related costs and transaction costs         $ 0 $ 2,100 0 3,200  
Prepayments for future purchases and other post-closing adjustments     $ 4,000            
Depreciation and Amortization Expense | HemaCare Corporation                  
Business Acquisition [Line Items]                  
Adjustments related to prior period             $ 600 9,600  
Depreciation and Amortization Expense | Citoxlab                  
Business Acquisition [Line Items]                  
Adjustments related to prior period               4,800  
Interest Expense | HemaCare Corporation                  
Business Acquisition [Line Items]                  
Adjustments related to prior period               8,800  
Interest Expense | Citoxlab                  
Business Acquisition [Line Items]                  
Adjustments related to prior period               $ 1,200  
Supplier                  
Business Acquisition [Line Items]                  
Equity interest                 80.00%
Noncontrolling interest ownership percentage     20.00%           20.00%
Supplier | Other Acquisitions                  
Business Acquisition [Line Items]                  
Equity interest     80.00%            
Noncontrolling interest ownership percentage     20.00%